Network analysis in the investigation of chronic respiratory diseases: From basics to application

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 9, 2014, Pages 981-988

  Diez, Diego ^a   Agustí, Alvar ^b   Wheelock, Craig E ^c  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF BARCELONA   (Spain)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gene regulatory network; Protein protein interaction network; Signaling network; Systems biology; Systems medicine

Indexed keywords

ANALYTIC METHOD; ARTICLE; CHRONIC RESPIRATORY TRACT DISEASE; COMPUTER PROGRAM; GENE REGULATORY NETWORK; HUMAN; KNOWLEDGE BASE; NETWORK ANALYSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SYSTEMS BIOLOGY; BREATHING DISORDER; CHRONIC DISEASE; MEDICAL RESEARCH; PROCEDURES; SIGNAL TRANSDUCTION;

BIOMEDICAL RESEARCH; CHRONIC DISEASE; HUMANS; RESPIRATION DISORDERS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84922393620     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201403-0421PP     Document Type: Article

References (50)

1. Sorokin SP. The cells of the lungs. In: Nettesheim P, Hanna MG Jr, Deatherage JW Jr, editors. Morphology of experimental respiratory carcinogenesis: proceedings of a Biology Division, Oak Ridge National Laboratory Conference. Gatlinburg, TN: National Technical Information Service; 1970. pp. 3-43.
2. Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med 2011;183:1129-1137.
3. Faner R, Rojas M, Macnee W, Agustí A. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;186:306-313.
4. Wu W, Kaminski N. Chronic lung diseases. Wiley Interdiscip Rev Syst Biol Med 2009;1:298-308.
5. Wheelock CE, Goss VM, Balgoma D, Nicholas B, Brandsma J, Skipp PJ, Snowden S, Burg D, D'Amico A, Horvath I, et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013;42:802-825.
6. st century through systems approaches. Biotechnol J 2012;7:992-1001.
7. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011;12:56-68.
8. Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J, Agusti A, Brightling C, Cambon-Thomsen A, Cesario A, et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 2011;3:43.
9. Studer SM, Kaminski N. Towards systems biology of human pulmonary fibrosis. Proc Am Thorac Soc 2007;4:85-91.
10. Ahmad F, Champion HC, Kaminski N. Toward systems biology of pulmonary hypertension. Circulation 2012;125:1477-1479.
11. Maher TM. Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine. Curr Opin Pulm Med 2013;19:460-465.
12. Dahlin A, Tantisira KG. Integrative systems biology approaches in asthma pharmacogenomics. Pharmacogenomics 2012;13:1387-1404.
13. Faner R, Cruz T, López-Giraldo A, Agustí A. Network medicine, multimorbidity and the lung in the elderly. Eur Respir J 2014;44:775-788.
14. Kitano H. Biological robustness. Nat Rev Genet 2004;5:826-837.
15. Schich M, Song C, Ahn YY, Mirsky A, Martino M, Barabási AL, Helbing D. Quantitative social science. A network framework of cultural history. Science 2014;345:558-562.
16. Sachs K, Perez O, Pe'er D, Lauffenburger DA, Nolan GP. Causal protein-signaling networks derived from multiparameter single-cell data. Science 2005;308:523-529.
17. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL. The human disease network. Proc Natl Acad Sci USA 2007;104:8685-8690.
18. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A. Reverse engineering of regulatory networks in human B cells. Nat Genet 2005;37:382-390.
19. Turan N, Kalko S, Stincone A, Clarke K, Sabah A, Howlett K, Curnow SJ, Rodriguez DA, Cascante M, O'Neill L, et al. A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease. PLOS Comput Biol 2011;7:e1002129.
20. Visscher S, Lucas PJ, Schurink CA, Bonten MJ. Modelling treatment effects in a clinical Bayesian network using Boolean threshold functions. Artif Intell Med 2009;46:251-266.
21. Novershtern N, Itzhaki Z, Manor O, Friedman N, Kaminski N. A functional and regulatory map of asthma. Am J Respir Cell Mol Biol 2008;38:324-336.
22. Parikh VN, Jin RC, Rabello S, Gulbahce N, White K, Hale A, Cottrill KA, Shaik RS, Waxman AB, Zhang YY, et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 2012;125:1520-1532.
23. Mitra K, Carvunis AR, Ramesh SK, Ideker T. Integrative approaches for finding modular structure in biological networks. Nat Rev Genet 2013;14:719-732.
24. Oberhardt MA, Goldberg JB, Hogardt M, Papin JA. Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J Bacteriol 2010;192:5534-5548.
25. Faner R, Gonzalez N, Cruz T, Kalko SG, Agustí A. Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: evidence of a gender effect. PLoS ONE 2014;9:e97491.
26. Vidal M, Cusick ME, Barabási AL. Interactome networks and human disease. Cell 2011;144:986-998.
27. Ideker T, Ozier O, Schwikowski B, Siegel AF. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002;18:S233-S240.
28. Wachi S, Yoneda K, Wu R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 2005;21:4205-4208.
29. Diez D, Goto S, Fahy JV, Erle DJ, Woodruff PG, Wheelock AM, Wheelock CE. Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics. BMC Med Genomics 2012;5:27.
30. Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 2012;13:613-626.
31. Alon U. Network motifs: theory and experimental approaches. Nat Rev Genet 2007;8:450-461.
32. Diez D, Hutchins AP, Miranda-Saavedra D. Systematic identification of transcriptional regulatory modules from protein-protein interaction networks. Nucleic Acids Res 2014;42:e6.
33. Hutchins AP, Diez D, Takahashi Y, Ahmad S, Jauch R, Tremblay ML, Miranda-Saavedra D. Distinct transcriptional regulatory modules underlie STAT3's cell type-independent and cell type-specific functions. Nucleic Acids Res 2013;41:2155-2170.
34. Menche J, Sharma A, Cho MH, Mayer RJ, Rennard SI, Celli B, Miller BE, Locantore N, Tal-Singer R, Ghosh S, et al. A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in chronic obstructive pulmonary disease. BMC Syst Biol 2014;8:S8.
35. Thomas S, Bonchev D. A survey of current software for network analysis in molecular biology. Hum Genomics 2010;4:353-360.
36. Diez D, Wheelock AM, Goto S, Haeggström JZ, Paulsson-Berne G, Hansson GK, Hedin U, Gabrielsen A, Wheelock CE. The use of network analyses for elucidating mechanisms in cardiovascular disease. Mol Biosyst 2010;6:289-304.
37. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-2504.
38. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
39. Renkonen J, Joenvaara S, Parviainen V, Mattila P, Renkonen R. Network analysis of single nucleotide polymorphisms in asthma. J Asthma Allergy 2010;3:177-186.
40. Hwang S, Son SW, Kim SC, Kim YJ, Jeong H, Lee D. A protein interaction network associated with asthma. J Theor Biol 2008;252:722-731.
41. Freishtat RJ, Benton AS, Watson AM, Wang Z, Rose MC, Hoffman EP. Delineation of a gene network underlying the pulmonary response to oxidative stress in asthma. J Investig Med 2009;57:756-764.
42. Grosdidier S, Ferrer A, Faner R, Pinero J, Roca J, Cosio B, Agusti A, Gea J, Sanz F, Furlong LI. Network medicine analysis of COPD multimorbidities. Respir Res 2014;15:111.
43. Elvira Consortium. Elvira: an environment for creating and using probabilistic graphical models. In: Gámez JA, Salmerón A, editors. Proceedings of the First European Workshop on Probabilistic Graphical Models (PGM'02). Cuenca, Spain: Electronic Proceedings; 2002. pp. 222-230.
44. Kutmon M, Kelder T, Mandaviya P, Evelo CT, Coort SL. CyTargetLinker: a cytoscape app to integrate regulatory interactions in network analysis. PLoS ONE 2013;8:e82160.
45. Bauer-Mehren A, Rautschka M, Sanz F, Furlong LI. DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks. Bioinformatics 2010;26:2924-2926.
46. Meyer PE, Lafitte F, Bontempi G. minet: a R/Bioconductor package for inferring large transcriptional networks using mutual information. BMC Bioinformatics 2008;9:461.
47. Zacher B, Abnaof K, Gade S, Younesi E, Tresch A, Fröhlich H. Joint Bayesian inference of condition-specific miRNA and transcription factor activities from combined gene and microRNA expression data. Bioinformatics 2012;28:1714-1720.
48. Beisser D, Klau GW, Dandekar T, Müller T, Dittrich MT. BioNet: an R-Package for the functional analysis of biological networks. Bioinformatics 2010;26:1129-1130.
49. Gonçalves E, Saez-Rodriguez J. Cyrface: an interface from Cytoscape to R that provides a user interface to R packages. F1000 Res 2013;2:192.
50. Shannon PT, Grimes M, Kutlu B, Bot JJ, Galas DJ. RCytoscape: tools for exploratory network analysis. BMC Bioinformatics 2013;14:217.